Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-03-011170
Filing Date
2003-03-31
Accepted
2003-03-31 13:20:17
Documents
10
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2106063z10-k.txt 10-K 269076
3 EXHIBIT 10.52 a2106063zex-10_52.txt EX-10.52 10076
4 EXHIBIT 10.53 a2106063zex-10_53.txt EX-10.53 5533
5 EXHIBIT 10.54 a2106063zex-10_54.txt EX-10.54 34908
6 EXHIBIT 10.55 a2106063zex-10_55.txt EX-10.55 3811
7 EXHIBIT 10.56 a2106063zex-10_56.txt EX-10.56 67557
8 EXHIBIT 10.57 a2106063zex-10_57.txt EX-10.57 31226
9 EXHIBIT 23.1 a2106063zex-23_1.txt EX-23.1 607
10 EXHIBIT 99.1 a2106063zex-99_1.txt EX-99.1 1642
11 EXHIBIT 99.2 a2106063zex-99_2.txt EX-99.2 1608
  Complete submission text file 0001047469-03-011170.txt   428643
Mailing Address FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address FIVE SCIENCE PARK NEW HAVEN CT 06511 2037731450
GENAISSANCE PHARMACEUTICALS INC (Filer) CIK: 0001110009 (see all company filings)

EIN.: 061338846 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30981 | Film No.: 03628857
SIC: 8731 Services-Commercial Physical & Biological Research